Related references
Note: Only part of the references are listed.Interpretation of Relative Efficacy and Effectiveness for Influenza Vaccines
Nathaniel M. Lewis et al.
CLINICAL INFECTIOUS DISEASES (2022)
A Real-World Clinical and Economic Analysis of Cell-Derived Quadrivalent Influenza Vaccine Compared to Standard Egg-Derived Quadrivalent Influenza Vaccines During the 2019-2020 Influenza Season in the United States
Victoria Divino et al.
OPEN FORUM INFECTIOUS DISEASES (2022)
Integrating Electronic Medical Records and Claims Data for Influenza Vaccine Research
Constantina Boikos et al.
VACCINES (2022)
Relative Effectiveness of Cell-based Versus Egg-based Quadrivalent Influenza Vaccines in Children and Adolescents in the United States During the 2019-2020 Influenza Season
Mahrukh Imran et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2022)
Relative Effectiveness of the Cell-derived Inactivated Quadrivalent Influenza Vaccine Versus Egg-derived Inactivated Quadrivalent Influenza Vaccines in Preventing Influenza-related Medical Encounters During the 2018-2019 Influenza Season in the United States
Constantina Boikos et al.
CLINICAL INFECTIOUS DISEASES (2021)
Clinical and Economic Outcomes Associated with Cell-Based Quadrivalent Influenza Vaccine vs. Standard-Dose Egg-Based Quadrivalent Influenza Vaccines during the 2018-19 Influenza Season in the United States
Girishanthy Krishnarajah et al.
VACCINES (2021)
Effectiveness of the Cell-Derived Inactivated Quadrivalent Influenza Vaccine in Individuals at High Risk of Influenza Complications in the 2018-2019 United States Influenza Season
Constantina Boikos et al.
OPEN FORUM INFECTIOUS DISEASES (2021)
Spread of Antigenically Drifted Influenza A(H3N2) Viruses and Vaccine Effectiveness in the United States During the 2018-2019 Season
Brendan Flannery et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Relative Effectiveness of the Cell-Cultured Quadrivalent Influenza Vaccine Compared to Standard, Egg-derived Quadrivalent Influenza Vaccines in Preventing Influenza-like Illness in 2017-2018
Constantina Boikos et al.
CLINICAL INFECTIOUS DISEASES (2020)
Interim Estimates of 2019–20 Seasonal Influenza Vaccine Effectiveness — United States, February 2020
Fatimah S. Dawood et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
A real-world study evaluating the relative vaccine effectiveness of a cell-based quadrivalent influenza vaccine compared to egg-based quadrivalent influenza vaccine in the US during the 2017-18 influenza season
Victoria Divino et al.
VACCINE (2020)
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2020-21 Influenza Season
Lisa A. Grohskopf et al.
MMWR RECOMMENDATIONS AND REPORTS (2020)
A Selective Review of Negative Control Methods in Epidemiology
Xu Shi et al.
CURRENT EPIDEMIOLOGY REPORTS (2020)
Antibodies Against Egg- and Cell-Grown Influenza A(H3N2) Viruses in Adults Hospitalized During the 2017-2018 Influenza Season
Min Z. Levine et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Improving Influenza Vaccine Effectiveness: Ways to Begin Solving the Problem
Arnold S. Monto et al.
CLINICAL INFECTIOUS DISEASES (2019)
Update: Influenza Activity - United States and Worldwide, May 19-September 28, 2019, and Composition of the 2020 Southern Hemisphere Influenza Vaccine
Scott Epperson et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2019)
Comparing Influenza Vaccine Types: The Path Toward Improved Influenza Vaccine Strategies
Brendan Flannery et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Relative Effectiveness of Cell-Cultured and Egg-Based Influenza Vaccines Among Elderly Persons in the United States, 2017-2018
Hector S. Izurieta et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Cell culture-derived influenza vaccines in the severe 2017-2018 epidemic season: a step towards improved influenza vaccine effectiveness
Ian G. Barr et al.
NPJ VACCINES (2018)
The hidden burden of influenza: A review of the extra-pulmonary complications of influenza infection
Subhashini A. Sellers et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2017)
Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains
Seth J. Zost et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Seasonal Influenza Infections and Cardiovascular Disease Mortality
Jennifer L. Nguyen et al.
JAMA CARDIOLOGY (2016)
Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies
Peter C. Austin et al.
STATISTICS IN MEDICINE (2015)
The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement
Eric I. Benchimol et al.
PLOS MEDICINE (2015)
Influenza surveillance in Europe: establishing epidemic thresholds by the Moving Epidemic Method
Tomas Vega et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2013)
被撤回的出版物: World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects (Retracted article. See vol. 135, pg. 2149, 2021)
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Doubly Robust Estimation of Causal Effects
Michele Jonsson Funk et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2011)
Role of acute infection in triggering acute coronary syndromes
Vicente F. Corrales-Medina et al.
LANCET INFECTIOUS DISEASES (2010)
Evidence of bias in estimates of influenza vaccine effectiveness in seniors
LA Jackson et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2006)
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data
HD Quan et al.
MEDICAL CARE (2005)
New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality
V Sundararajan et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2004)
Share Paper
